Loading
institutionsInstitution
Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center (Ichilov) is Tel Aviv University's main teaching hospital; its oncology division runs a large trial programme in gastrointestinal, breast and genitourinary cancers, and Ofer Merimsky's unit is Israel's reference centre for sarcoma.
Also called: Ichilov HospitalSouraskyTel Aviv Medical Center
Overview
The Tel Aviv Sourasky Medical Center (Ichilov) is the primary teaching hospital of Tel Aviv University's medical faculty and one of Israel's largest hospitals. Its oncology division under Ido Wolf runs a large clinical trials programme in gastrointestinal, breast and genitourinary cancers, Ofer Merimsky's unit is Israel's reference for sarcoma, Ravit Geva leads gastrointestinal oncology, and the hospital has strong neurosurgical oncology, haematology and radiotherapy departments. Sourasky participates in international precision oncology and immunotherapy trials and hosts translational laboratories in cancer immunology and genomics.
Location
Tel Aviv, IL
Type
hospital · Tel Aviv University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#320 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Tel Aviv Sourasky Medical Center, including child institutions. 368 works · 4,029 citations · 63% open access · 13% clinical trials · 1% reviews.
Oncology works per year
972022
712023
682024
772025
552026
Most works
- Ron Ram52 works
- Irit Avivi26 works
- Ido Wolf25 works
- Ravit Geva22 works
- Amir Sonnenblick19 works
- Odelia Amit17 works
- Chava Perry17 works
- Ofrat Beyar‐Katz16 works
- Yaël C. Cohen16 works
- Adam D. Cohen12 works
Most cited
- Oncology clinical trials
- Sarcoma
- Gastrointestinal oncology
- Neuro-oncology
- Haematology
Eli Sprecher
CEO, Tel Aviv Sourasky Medical Center (Ichilov)
DermatologyGenetics of skin diseaseHospital leadership
Dermatologist and geneticist who has been chief executive of Tel Aviv Sourasky Medical Center, a major Israeli academic hospital, since 2024.
Zelig Eshhar
Immunologist; professor emeritus, Weizmann Institute of Science, latterly Immunology Laboratory, Tel Aviv Sourasky Medical Center
Cancer immunologyChimeric antigen receptorsAdoptive cell therapy
The immunologist who, in 1989, first gave a T cell an antibody's aim. Every CAR-T product on the market descends from that experiment.
Similar pages
- PersonGal Markel
Shares Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Sheba Medical Center, Immune checkpoint inhibitors.
- PersonJacob Schachter
Shares Tel Aviv University, Sheba Medical Center, Immune checkpoint inhibitors.
- PersonEitan Friedman
Shares Tel Aviv University, Sheba Medical Center, HR-positive / HER2-negative breast cancer.
- PersonMichal Besser
Shares Tel Aviv University, Sheba Medical Center.
- CompanyAlpha Tau Medical
Shares Tel Aviv University, Glioma & glioblastoma.
- InstitutionRambam Health Care Campus
Shares Sheba Medical Center, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionWeizmann Institute of Science
Shares Zelig Eshhar, Sheba Medical Center, Colorectal cancer.
- Key paperPopulation-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Shares Sheba Medical Center, HR-positive / HER2-negative breast cancer.